Cilostazol alleviate nicotine induced cardiomyocytes hypertrophy through modulation of autophagy by CTSB/ROS/p38MAPK/JNK feedback loop.

Abstract

Nicotine is proved to be an important factor for cardiac hypertrophy. Autophagy is important cell recycling system involved in the regulation of cardiac hypertrophy. Cilostazol, which is often used in the management of peripheral vascular disease. However, the effects of cilostazol on nicotine induced autophagy and cardiac hypertrophy are unclear. Here, we aim to determine the role and molecular mechanism of cilostazol in alleviating nicotine-induced cardiomyocytes hypertrophy through modulating autophagy and the underlying mechanisms. Our results clarified that nicotine stimulation caused cardiomyocytes hypertrophy and autophagy flux impairment significantly in neonatal rat ventricular myocytes (NRVMs), which were evidenced by augments of LC3-II and p62 levels, and impaired autophagosomes clearance. Interestingly, cathepsin B (CTSB) activity decreased dramatically after stimulation with nicotine in NRVMs, which was crucial for substrate degradation in the late stage of autophagy process, and cilostazol could reverse this effect dramatically. Intracellular ROS levels were increased significantly after nicotine exposure. Meanwhile, p38MAPK and JNK were activated after nicotine treatment. By using ROS scavenger N-acetyl-cysteine (NAC) could reverse the effects of nicotine by down-regulation the phosphorylation of p38MAPK and JNK pathways, and pretreatment of specific inhibitors of p38MAPK and JNK could restore the autophagy impairment and cardiomyocytes hypertrophy induced by nicotine. Moreover, CTSB activity of lysosome regained after the treatment with cilostazol. Cilostazol also inhibited the ROS accumulation and the activation of p38MAPK and JNK, which providing novel connection between lysosome CTSB and ROS/p38MAPK/JNK related oxidative stress pathway. This is the first demonstration that cilostazol could alleviate nicotine induced cardiomyocytes hypertrophy through restoration of autophagy flux by activation of CTSB and inhibiting ROS/p38/JNK pathway, exhibiting a feedback loop on regulation of autophagy and cardiomyocytes hypertrophy.

• Authors: Shu-Ya Wang, Xi Ni, Ke-Qing Hu, Fan-Liang Meng, Min Li, Xiao-Li Ma, Ting-Ting Meng, Hui-Hui Wu, Di Ge, Jing Zhao, Ying Li, Guo-Hai Su
• Journal: International journal of biological sciences (Int J Biol Sci) Vol. 16 Issue 11 Pg. 2001-2013 ( 2020) ISSN: 1449-2288 [Electronic] Australia
• PMID: 32398966 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © The author(s).

Chemical References

• Bronchodilator Agents
• Nicotinic Agonists
• Proto-Oncogene Proteins
• Nicotine
• Receptor Protein-Tyrosine Kinases
• Ros1 protein, rat
• p38 Mitogen-Activated Protein Kinases
• MAP Kinase Kinase 4
• Cathepsin B
• Ctsb protein, rat
• Cilostazol

Topics

• Animals
• Bronchodilator Agents (pharmacology)
• Cathepsin B (genetics, metabolism)
• Cilostazol (pharmacology)
• Gene Expression Regulation (drug effects)
• MAP Kinase Kinase 4 (genetics, metabolism)
• Myocytes, Cardiac (drug effects)
• Nicotine (toxicity)
• Nicotinic Agonists (toxicity)
• Proto-Oncogene Proteins (genetics, metabolism)
• Rats
• Receptor Protein-Tyrosine Kinases (genetics, metabolism)
• p38 Mitogen-Activated Protein Kinases (genetics, metabolism)